Ede Ronald Hao Xi reduced his holdings in INNOVENT BIO (01801) by approximately 752,400 shares, with a price of approximately HK$88.50 per share.
On July 6th, Ede Ronald Hao Xi reduced his holdings of Sunshine Biopharma (01801) by 752,381 shares, with a price of 88.5042 Hong Kong dollars per share, for a total amount of 66.589 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on July 6, Ede Ronald Hao Xi reduced his holdings of INNOVENT BIO (01801) by 752,381 shares, at a price of 88.5042 Hong Kong dollars per share, for a total amount of 66.589 million Hong Kong dollars. After the reduction, the latest number of shares held is approximately 4.9223 million shares, with a new holding percentage of 0.28%.
Related Articles
HK Stock Market Move | Contemporary Amperex Technology (03750) fell nearly 9% at the close of trading, mainstream new energy vehicle companies adjust power battery procurement strategies, introduce second-tier battery manufacturers.
$7.7 billion offer exceeds Castlelake's! Apollo enters the bidding for EasyJet Airlines (ESYJY.US), two major American private equity firms may start a bidding war.
HK Stock Market Move | Lithium battery concept stocks fell again, as new production capacity on the supply side was released. Market expectations of strong industry demand have been shattered.
HK Stock Market Move | Contemporary Amperex Technology (03750) fell nearly 9% at the close of trading, mainstream new energy vehicle companies adjust power battery procurement strategies, introduce second-tier battery manufacturers.
$7.7 billion offer exceeds Castlelake's! Apollo enters the bidding for EasyJet Airlines (ESYJY.US), two major American private equity firms may start a bidding war.
HK Stock Market Move | Lithium battery concept stocks fell again, as new production capacity on the supply side was released. Market expectations of strong industry demand have been shattered.
RECOMMEND
